PE: How do global pharma growth strategies differ from domestic strategies? Ackerman: There are two different models for ...

TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany, November 17, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a ...

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) has provided an update. Shandong Xinhua Pharmaceutical Company Limited has ...

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says ...

Entered into an Agreement to be acquired by QOL Medical Net product sales for the third quarter of 2025 reached $4.3 million; ...

The bioindustry is establishing itself as a core sector of national strategy, going beyond healthcare, amid a complex environment shaped by the ...

STOCKHOLM, SE / ACCESS Newswire / November 11, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - ...

This Big Pharma could boost profits significantly in the years ahead. It’s increasingly clear that broad bets on healthcare don’t make sense as a refuge from the market chaos. Pfizer Stock’s Fall to ...

Experts agree that without immediate policy interventions, Bangladesh risks falling behind regional competitors while facing rising medicine costs at home ...

Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.

Known for developing and manufacturing complex pharmaceutical formulations, the company delivered strong quarterly results ...